Skip to content

NLST 2011 — low-dose CT screening

One-paragraph summary

The National Lung Screening Trial randomized 53,454 high-risk current or former smokers aged 55–74 to three annual rounds of low-dose CT or chest radiography. Low-dose CT reduced lung-cancer mortality by 20.0% and all-cause mortality by 6.7% relative to radiography. The result established mortality efficacy for CT screening, but also documented a very high positive-screen rate, most of which was false positive under the trial's nodule definition.

Design and results

Element Result
Population 53,454 high-risk participants; ages 55–74; ≥30 pack-years; current or quit within 15 years
Intervention Three annual LDCT screens
Comparator Three annual chest-radiograph screens
Lung-cancer mortality 20.0% relative reduction with LDCT
All-cause mortality 6.7% relative reduction
Positive screens Common; the large majority were false positives

LUSC relevance

LUSC is tightly associated with the tobacco exposure defining the trial population, but NLST was not powered for a histology-specific mortality endpoint. Central LUSCs may present differently from peripheral nodules, and rapidly growing interval cancers can remain problematic. The trial supports programmatic LDCT, not symptom triage or stand-alone scanning without nodule management.

Limitations

  • Conducted at experienced US centers with a healthier-volunteer effect.
  • Comparator was chest radiography, not usual care with no screening.
  • Eligibility excluded many people at risk through radon, occupational exposure, or lighter smoking histories.
  • Early positive thresholds produced more false positives than modern volumetric protocols.
  • Benefit depends on ability to complete diagnostic work-up and curative treatment.

Why it matters

NLST supplies the causal mortality anchor behind US screening policy. For LUSC, its deeper lesson is systems-based: mortality reduction requires eligibility, high-quality acquisition, structured nodule management, diagnostic capacity, treatment fitness, cessation support, and longitudinal adherence.

Cited by wiki pages

  • Overview
  • Epidemiology and smoking
  • Screening and early detection

Verified citation

National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. [PMID 21714641](https://pubmed.ncbi.nlm.nih.gov/21714641/){target="_blank" rel="noopener"}